Advanced search
Publication Cover
Postgraduate Medicine Volume 126, 2014 - Issue 5
Submit an article Journal homepage
307
Views
18
CrossRef citations to date
0
Altmetric
Clinical Features

Analysis of Buprenorphine/Naloxone Dosing Impact on Treatment Duration, Resource Use and Costs in the Treatment of Opioid-Dependent Adults: A Retrospective Study of US Public and Private Health Care Claims

Amine Khemiri Health Economist, Creativ-Ceutical, Paris, France
, MSc,
Elizaveta Kharitonova Health Economist, Creativ-Ceutical, Chicago, IL
, MSc,
Vladimir Zah Health Economics Director, ZRx Outcomes Research Inc., Mississauga, Ontario, Canada
, PhD(c),
Jane Ruby Medical Affairs Manager, Reckitt Benckiser Pharmaceuticals, Inc., Richmond, VA
, PhD &
Mondher Toumi University of Aix-Marseille, Université de la Méditerranée, Faculté de Médecine, Laboratoire de Santé Publique, Marseille, FranceCorrespondence[email protected]
, MD, PharmD, PhD
Pages 113-120 | Published online: 13 Mar 2015

Citations (18)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Naoko A Ronquest, Tina M Willson, Leslie B Montejano, Vijay R Nadipelli & Bernd A Wollschlaeger. (2018) Relationship between buprenorphine adherence and relapse, health care utilization and costs in privately and publicly insured patients with opioid use disorder. Substance Abuse and Rehabilitation 9, pages 59-78.
Read now
Icro Maremmani, Benjamin Rolland, Lorenzo Somaini, Carlos Roncero, Jens Reimer, Nat Wright, Richard Littlewood, Peter Krajci, Hannu Alho, Oscar D’Agnone & Nicolas Simon. (2016) Buprenorphine dosing choices in specific populations: review of expert opinion. Expert Opinion on Pharmacotherapy 17:13, pages 1727-1731.
Read now

Articles from other publishers (16)

Sarah M. Allen, Taylor A. Nichols, Janet Fawcett & Show Lin. (2022) Outcomes associated with once‐daily versus multiple‐daily dosing of buprenorphine/naloxone for opioid use disorder. The American Journal on Addictions 31:3, pages 173-179.
Crossref
Alene Kennedy-Hendricks, Cameron J. Schilling, Alisa B. Busch, Elizabeth A. Stuart, Haiden A. Huskamp, Mark K. Meiselbach, Colleen L. Barry & Matthew D. Eisenberg. (2021) Impact of High Deductible Health Plans on Continuous Buprenorphine Treatment for Opioid Use Disorder. Journal of General Internal Medicine 37:4, pages 769-776.
Crossref
Md Mahmudul Hasan, Gary J. Young, Jiesheng Shi, Prathamesh Mohite, Leonard D. Young, Scott G. Weiner & Md. Noor-E-Alam. (2021) A machine learning based two-stage clinical decision support system for predicting patients’ discontinuation from opioid use disorder treatment: retrospective observational study. BMC Medical Informatics and Decision Making 21:1.
Crossref
Md Mahmudul Hasan, Md. Noor-E-Alam, Prathamesh Mohite, Md Saiful Islam, Alicia Sasser Modestino, Alyssa M. Peckham, Leonard D. Young & Gary J. Young. (2021) Patterns of patient discontinuation from buprenorphine/naloxone treatment for opioid use disorder: A study of a commercially insured population in Massachusetts. Journal of Substance Abuse Treatment 131, pages 108416.
Crossref
Mark OlfsonVictoria (Shu) ZhangMarissa KingRamin Mojtabai. (2021) Changes in Buprenorphine Treatment After Medicaid Expansion. Psychiatric Services 72:6, pages 633-640.
Crossref
Mark OlfsonVictoria ZhangMichael SchoenbaumMarissa King. (2020) Buprenorphine Treatment By Primary Care Providers, Psychiatrists, Addiction Specialists, And Others. Health Affairs 39:6, pages 984-992.
Crossref
Katie J. Binger, Elayne D. Ansara, Talia M. Miles & Samantha L. Schulte. (2020) Relapse rates among veterans on maintenance doses of combination buprenorphine and naloxone for opioid use disorder. Mental Health Clinician 10:3, pages 80-84.
Crossref
Yea-Jen HsuJill A. MarstellerSarah G. KachurMichael I. Fingerhood. (2019) Integration of Buprenorphine Treatment with Primary Care: Comparative Effectiveness on Retention, Utilization, and Cost. Population Health Management 22:4, pages 292-299.
Crossref
Hillary Samples, Arthur Robin Williams, Mark Olfson & Stephen Crystal. (2018) Risk factors for discontinuation of buprenorphine treatment for opioid use disorders in a multi-state sample of Medicaid enrollees. Journal of Substance Abuse Treatment 95, pages 9-17.
Crossref
Marcia Reinhart, Lauren M. Scarpati, Noam Y. Kirson, Cody Patton, Nina Shak & Jennifer G. Erensen. (2018) The Economic Burden of Abuse of Prescription Opioids: A Systematic Literature Review from 2012 to 2017. Applied Health Economics and Health Policy 16:5, pages 609-632.
Crossref
Natalia Shcherbakova, Gary Tereso, Jacqueline Spain & Robert J. Roose. (2018) Treatment Persistence Among Insured Patients Newly Starting Buprenorphine/Naloxone for Opioid Use Disorder. Annals of Pharmacotherapy 52:5, pages 405-414.
Crossref
Ajay Manhapra, Ismene Petrakis & Robert Rosenheck. (2017) Three-year retention in buprenorphine treatment for opioid use disorder nationally in the Veterans Health Administration. The American Journal on Addictions 26:6, pages 572-580.
Crossref
Brendan Saloner, Matthew Daubresse & G. Caleb Alexander. (2017) Patterns of Buprenorphine-Naloxone Treatment for Opioid Use Disorder in a Multistate Population. Medical Care 55:7, pages 669-676.
Crossref
Sean M. Murphy & Daniel Polsky. (2016) Economic Evaluations of Opioid Use Disorder Interventions. PharmacoEconomics 34:9, pages 863-887.
Crossref
Anthony J. Accurso & Darius A. Rastegar. (2016) The Effect of a Payer-Mandated Decrease in Buprenorphine Dose on Aberrant Drug Tests and Treatment Retention Among Patients with Opioid Dependence. Journal of Substance Abuse Treatment 61, pages 74-79.
Crossref
Richard J. Bodnar. (2016) Endogenous opiates and behavior: 2014. Peptides 75, pages 18-70.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.